登录

BeauCare Raises ¥100M in Series D Funding Round from Fortune Capital

作者: Mailman 2021-04-13 09:06
联合丽格
http://www.beaucare.org/
企业数据由 动脉橙 提供支持
高端医疗美容服务提供商 | D轮 | 运营中
中国-北京
2021-10-27
胡杨林资本
查看

(VCBeat) Mar. 31, 2021 -- Recently, BeauCare Clinics Investment Co., Ltd. ("BeauCare"), a leading chain-store cosmetology hospital company, has raised hundreds of millions of yuan in a Series D financing from Fortune Venture Capital. BeauCare will use the proceeds to further consolidate its top position in the industry, explore innovative businesses, lead the development of medical cosmetology, and better contribute to the inner cycle of the domestic economy.


Founded in November 2012 and headquartered in Beijing, BeauCare is an international chain-store group specializing in the investment and management of international high-end cosmetology hospitals. BeauCare has become a large investment and operation platform to support doctors' entrepreneurship in the medical cosmetology industry in China. Learning from the international common-mode and cooperating with the industry's outstanding experts, BeauCare invests in the establishment of hospitals and strives to provide high-quality and safe services for tens of millions of Chinese customers.


BeauCare is one of the earliest chain-store and investment groups that supports doctors to start their own businesses in China. As of March 2021, BeauCare has invested, operated and prepared to build more than 50 institutions in more than 10 cities across the country, covering Beijing, Shanghai, Guangzhou, Shenzhen, Tianjin, Chongqing, Dalian, Nanjing, Hangzhou, Wuhan and other first-tier and provincial capital cities.  The services provided by those hospitals involve plastic and cosmetic surgery, micro-dose plastic surgery, laser dermatology, body sculpture, cosmetic dentistry, ophthalmology and many other fields.


>>>>

About Fortune Venture Capital (Fortune Capital)


Founded in April 2000, Fortune Capital is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focuses its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.


Fortune Capital is ranked among the highest performing VC/PE firms in China. In addition to providing capital, Fortune Capital provides its investee companies with personalized value-added services.

注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

【首发】蓝皓生物完成数千万元A轮融资,加快推进口腔再生修复和医美产品注册及市场化

SinoBiom Raises ¥100 Million in Series B Financing

【首发】再生技术领导者圣博玛完成数亿元B轮融资,布局全球医美市场

Weiyun AI Brings in ¥100 million in a New Round of Financing

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Artivila Lands ¥150 Million Series Pre-A Funding

2021-04-13
下一篇

b-ONE Ortho Completes ¥100M Series B Financing

2021-04-13